Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedEnrollment has closed for this study ('No longer looking for participants'), reflecting termination of accrual. New user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a minor header formatting change (Intervention/Treatment) and a revision note (Revision: v3.6.0).SummaryDifference0.6%

- Check15 days agoChange DetectedThe page revision tag has been updated from v3.5.4 to v3.5.5, indicating a new release of the page template or CMS. This update does not affect the study information displayed.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a site deployment. It does not change the study details or results, only the page's underlying version.SummaryDifference0.1%

- Check44 days agoChange DetectedNo changes detected for the page details; the study record remains as originally published.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.3 appears on the page, replacing the previous Revision: v3.5.2. This reflects a page revision or platform update.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision metadata updated: added Revision: v3.5.2 and removed Revision: v3.5.0. This change does not affect the page content or study information.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.